January 14, 2019 / 1:21 PM / 2 months ago

BRIEF-Ferring To Acquire U.S. Commercialization Rights For Generic Version Of Ganirelix Acetate Injection

Jan 14 (Reuters) - Ferring Pharmaceuticals:

* FERRING PHARMACEUTICALS - TO ACQUIRE U.S. COMMERCIALIZATION RIGHTS FOR GENERIC VERSION OF GANIRELIX ACETATE INJECTION FROM SUN PHARMACEUTICAL INDUSTRIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below